Alzinova (ALZ)

Last close As at 05/03/2026

SEK0.59

−0.01 (−1.50%)

Market capitalisation

SEK62m

Alzinova is a Swedish biopharmaceutical company in clinical development specializing in the treatment of Alzheimer’s disease.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Tord Labuda

    CEO

  • Erik Kullgren

    CFO